搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xenopus laevis Transcription factor Sox-17-beta.3 (sox17b.3) CSB-YP398205XBE
CSB-EP398205XBE
CSB-BP398205XBE
CSB-MP398205XBE
CSB-EP398205XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Formation of crista junctions protein 1 (FCJ1), partial CSB-YP398206MTM
CSB-EP398206MTM
CSB-BP398206MTM
CSB-MP398206MTM
CSB-EP398206MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Protein transport protein SEC23 (SEC23), partial CSB-YP398207MTM
CSB-EP398207MTM
CSB-BP398207MTM
CSB-MP398207MTM
CSB-EP398207MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Catabolic 3-dehydroquinase (DQD1) CSB-YP398208MTM
CSB-EP398208MTM
CSB-BP398208MTM
CSB-MP398208MTM
CSB-EP398208MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Probable proteasome subunit beta type-2 (PRO2) CSB-YP398209MTM
CSB-EP398209MTM
CSB-BP398209MTM
CSB-MP398209MTM
CSB-EP398209MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Histone H2A.1 (HTA1) CSB-YP398210MTM
CSB-EP398210MTM
CSB-BP398210MTM
CSB-MP398210MTM
CSB-EP398210MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Ribosome biogenesis protein NSA2 (NSA2) CSB-YP398211MTM
CSB-EP398211MTM
CSB-BP398211MTM
CSB-MP398211MTM
CSB-EP398211MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Transcription factor BYE1 (BYE1), partial CSB-YP398212MTM
CSB-EP398212MTM
CSB-BP398212MTM
CSB-MP398212MTM
CSB-EP398212MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Genetic interactor of prohibitins 3, mitochondrial (GEP3), partial CSB-YP398213MTM
CSB-EP398213MTM
CSB-BP398213MTM
CSB-MP398213MTM
CSB-EP398213MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii ATP-dependent RNA helicase FAL1 (FAL1) CSB-YP398214MTM
CSB-EP398214MTM
CSB-BP398214MTM
CSB-MP398214MTM
CSB-EP398214MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Tethering factor for nuclear proteasome STS1 (STS1) CSB-YP398215MTM
CSB-EP398215MTM
CSB-BP398215MTM
CSB-MP398215MTM
CSB-EP398215MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Pre-mRNA-splicing ATP-dependent RNA helicase PRP28 (PRP28), partial CSB-YP398216MTM
CSB-EP398216MTM
CSB-BP398216MTM
CSB-MP398216MTM
CSB-EP398216MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Golgi to ER traffic protein 1 (GET1), partial CSB-YP398217MTM1
CSB-EP398217MTM1
CSB-BP398217MTM1
CSB-MP398217MTM1
CSB-EP398217MTM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Protein SUS1 (SUS1) CSB-YP398218MTM
CSB-EP398218MTM
CSB-BP398218MTM
CSB-MP398218MTM
CSB-EP398218MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii 40S ribosomal protein S0 (RPS0) CSB-YP398219MTM
CSB-EP398219MTM
CSB-BP398219MTM
CSB-MP398219MTM
CSB-EP398219MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii ATPase GET3 (GET3) CSB-YP398220MTM
CSB-EP398220MTM
CSB-BP398220MTM
CSB-MP398220MTM
CSB-EP398220MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Translation machinery-associated protein 22 (TMA22) CSB-YP398221MTM
CSB-EP398221MTM
CSB-BP398221MTM
CSB-MP398221MTM
CSB-EP398221MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii U3 small nucleolar RNA-associated protein 10 (UTP10), partial CSB-YP398222MTM
CSB-EP398222MTM
CSB-BP398222MTM
CSB-MP398222MTM
CSB-EP398222MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Lysophospholipase NTE1 (NTE1), partial CSB-YP398223MTM
CSB-EP398223MTM
CSB-BP398223MTM
CSB-MP398223MTM
CSB-EP398223MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Autophagy-related protein 18 (ATG18), partial CSB-YP398224MTM
CSB-EP398224MTM
CSB-BP398224MTM
CSB-MP398224MTM
CSB-EP398224MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>